Best Endocrine Cancer Treatment in Coimbatore

The endocrine system is the body's chemical messenger network, a collection of hormone-producing glands regulating everything from metabolism and blood sugar to stress responses and growth. When cancer arises in these hormone-producing tissues, it creates a uniquely complex challenge: not just a tumor to be removed, but a hormonal disturbance to be corrected, and often a genetic syndrome to be evaluated and managed across an entire family.

Endocrine cancers are among the most fascinating and misunderstood malignancies in oncology. Endocrine cancers can range from slow-growing neuroendocrine tumors (NETs), which may require years of monitoring, to aggressive anaplastic cancers that require urgent multimodal treatment. At GEM Cancer Centre in Coimbatore, our endocrine oncology program provides a full range of personalized care, including surgery, nuclear medicine, medical treatment, and hormone treatment, for patients with neuroendocrine tumors, adrenal cancers, pituitary tumors, and other rare endocrine.

Types of Endocrine Cancer

• Neuroendocrine Tumors (NETs): arise from diffuse neuroendocrine cells throughout the GI tract, pancreas, and lungs. Range from indolent Grade 1 tumors (Ki-67 less than 2%) to aggressive Grade 3 neuroendocrine carcinomas. Functional NETs secrete hormones, causing carcinoid syndrome, insulinoma, gastrinoma, or other syndromes.
• Adrenocortical Carcinoma (ACC): is a rare and often aggressive cancer of the adrenal cortex; it may secrete cortisol (Cushing's syndrome) or androgens (virilization) or present as a large nonfunctional adrenal mass.
• Pheochromocytoma and paraganglioma: are tumors of the adrenal medulla or extra-adrenal paraganglia that secrete catecholamines, causing hypertension, sweating, and headache. Up to 40% have germline mutations.
• Pituitary tumors: are mostly benign adenomas but functionally significant; they cause visual field defects from optic chiasm compression and hormonal syndromes from excess GH, prolactin, or ACTH secretion.

Recognising Endocrine Cancer Symptoms

Neuroendocrine Tumour Symptoms

• Carcinoid syndrome: Episodic flushing of the face and neck, explosive diarrhoea, wheezing, and abdominal cramping, typically triggered by stress, exercise, or certain foods.
• Insulinoma Recurrent hypoglycemia: sweating, confusion, trembling, and reduced consciousness, particularly early morning or after fasting.
• Gastrinoma: Severe, recurrent peptic ulcers and chronic diarrhoea from excessive gastric acid secretion.

Adrenal and Pituitary Tumour Symptoms

• Cushing's syndrome (ACC or ACTH-secreting pituitary tumor): Rapid central weight gain, purple stretch marks, thin skin, easy bruising, high blood pressure, and high blood sugar.
• Pheochromocytoma: Episodic severe headaches, profuse sweating, and heart palpitations triggered by physical activity or medications.
• Acromegaly (GH-secreting pituitary adenoma): Coarsening of facial features, enlarged hands and feet, jaw protrusion, new spacing between teeth in adults.
• Incidentaloma: Many endocrine tumours are discovered incidentally on CT or MRI done for other reasons; all require systematic hormonal and imaging evaluation.

Diagnosis at GEM Cancer Centre

• Hormonal blood and urine tests 24-hour urine or plasma metanephrines for pheochromocytoma; serum chromogranin A and 24-hour urine 5-HIAA for NETs; overnight dexamethasone suppression test for Cushing's; fasting insulin, C-peptide, and glucose ratio for insulinoma.
• Gallium-68 DOTATATE PET-CT (Ga-68 PET) the most sensitive functional imaging for somatostatin receptor-positive NETs; the gold standard for NET staging at GEM Cancer Centre.
• CT and MRI abdomen anatomical imaging for adrenal and pancreatic tumours.
• Dynamic gadolinium-enhanced MRI of the pituitary detects small microadenomas with superior sensitivity to CT.
• Adrenal CT with washout protocol distinguishes benign adenoma from ACC or pheochromocytoma.
• Core needle biopsy or FNAC for histological confirmation and Ki-67 grading of NETs never performed for suspected pheochromocytoma.
• Germline genetic testing offered to all patients with paraganglioma, pheochromocytoma, young-onset NETs, or strong family history.

Treatment Options at GEM Cancer Centre

Robotic Adrenalectomy

For adrenal tumors, both pheochromocytoma and smaller ACCs, robotic adrenalectomy via retroperitoneoscopic or transperitoneal approach offers the most precise operation available. For pheochromocytoma, meticulous preoperative alpha-blockade (10–14 days of phenoxybenzamine or doxazosin) is essential to prevent fatal intraoperative hypertensive crisis.

Robotic Pancreatic NET Surgery

Pancreatic NETs require surgical resections for all localized diseases. Small insulinomas near the surface are enucleated robotically. Larger body/tail NETs require robotic distal pancreatectomy. Head tumors may require the Whipple procedure. GEM Cancer Centre's pancreatic surgery expertise ensures safe, oncologically sound NET resection.

Somatostatin Analogue Therapy

Monthly long-acting somatostatin analogues, octreotide LAR or lanreotide autogel, both control hormonal symptoms of functional tumors (carcinoid syndrome) and exert direct anti-tumor activity, prolonging progression-free survival in somatostatin receptor-positive NETs.

Peptide Receptor Radionuclide Therapy (PRRT)

PRRT with Lutetium-177 DOTATATE (Lutathera) delivers targeted beta radiation directly to somatostatin receptor-expressing NET cells throughout the body. The NETTER-1 trial demonstrated a 79% reduction in disease progression risk. GEM Cancer Centre's Nuclear Medicine department provides PRRT eligibility assessment and coordinates therapy.

Targeted Therapy: Everolimus and Sunitinib

For progressive pancreatic NETs, both everolimus (mTOR inhibitor) and sunitinib (TKI) are approved and available at GEM Cancer Centre. For extra-pancreatic NETs, everolimus provides disease stabilization in carcinoid tumors failing somatostatin analogues.

Mitotane and Systemic Therapy for Adrenocortical Carcinoma

For localized resectable ACC, en bloc radical adrenalectomy is the only potentially curative treatment. Adjuvant mitotane is recommended for high-risk resected ACC. For metastatic ACC, EDP-mitotane (etoposide, doxorubicin, cisplatin, plus mitotane) is the reference first-line regimen.

Why Choose GEM Cancer Centre?

• The dedicated endocrine tumor board endocrinology, surgery, nuclear medicine, and oncology reviews every case together.
• Gallium-68 DOTATATE PET-CT is the gold standard NET staging tool available in Coimbatore.
• Robotic adrenalectomy program expert in pheochromocytoma and ACC surgery with full preoperative alpha-blockade protocol.
• PRRT eligibility assessment and coordination: Nuclear Medicine department led by Dr. Brithika T Y.
• Germline genetic testing and counseling protect patients and their families.
• Tamil Nadu's most comprehensive rare endocrine cancer programme in one centre.

When to See a Doctor

See an endocrine oncologist at GEM Cancer Centre in Coimbatore if you have an adrenal mass on CT that has not been fully evaluated; if you have episodic unexplained sweating, headaches, and high blood pressure; if blood sugar control has suddenly deteriorated without explanation; if you have been diagnosed with a NET or carcinoid; or if a family member has MEN1, MEN2, VHL, or paraganglioma syndrome. These conditions require subspecialist evaluation, and early assessment dramatically changes outcomes.

Frequently Asked Questions

What is the difference between an endocrine tumor and a carcinoid?

"Carcinoid" is an older term for well-differentiated neuroendocrine tumors, particularly those arising in the small intestine, appendix, and lungs. Modern terminology uses the term 'well-differentiated NET Grade 1 or 2. ''Carcinoid syndrome occurs when midgut NETs metastasize to the liver and secrete serotonin and vasoactive substances directly into the systemic circulation.

Can an adrenal incidentaloma become cancer?

Most adrenal incidentalomas are benign, non-functioning adenomas that never require treatment, only periodic imaging surveillance. Features increasing concern for malignancy include size greater than 4 cm, irregular borders, CT density greater than 10 Hounsfield units, and slow washout of contrast. Hormonal evaluation for pheochromocytoma, Cushing's, and aldosteronism is mandatory for all adrenal incidentalomas.

Is PRRT (Lutetium DOTATATE) available in Coimbatore?

GEM Cancer Centre's Nuclear Medicine department can assess eligibility for PRRT with Lutetium-177 DOTATATE by performing Gallium-68 DOTATATE PET-CT. Patients who have enough somatostatin receptors and healthy kidney and bone marrow function are scheduled for PRRT treatment, with GEM handling all the necessary checks before and after the treatment.

Do all family members of a NET patient need to be tested?

Not all NETs are hereditary. However, if a patient has a genetic change in MEN1, VHL, SDH, or another related gene, their close family members have a 50% chance of having it too and should be given the option for genetic testing. Mutation carriers can then enter an appropriate cancer surveillance program before tumors develop.

How is pheochromocytoma surgery made safe?

Pheochromocytoma surgery requires 10–14 days of preoperative alpha-adrenergic blockade, volume loading to prevent postoperative hypotension, an experienced anesthesia team, and a surgeon expert in minimally invasive adrenal surgery. GEM Cancer Centre follows these protocols rigorously; any pheochromocytoma operated on without proper preparation risks a fatal intraoperative hypertensive crisis.

What is the best endocrine cancer treatment in Coimbatore?

GEM Cancer Centre provides robotic adrenalectomy, surgery for pancreatic NET, somatostatin analogue therapy, checks for PRRT eligibility, targeted therapy (everolimus, sunitinib), and a full evaluation of hereditary syndromes, all reviewed by our